Functional significance of the signal transduction pathways Akt and Erk in ovarian follicles:

School of Agriculture Food Science and Veterinary Medicine, Conway Institute, College of Life Science, University College Dublin, Belfield, Dublin 4, Ireland.
Journal of Ovarian Research (Impact Factor: 2.43). 02/2008; 1(1):2. DOI: 10.1186/1757-2215-1-2
Source: PubMed


The intracellular signalling mechanisms that regulate ovarian follicle development are unclear; however, we have recently shown differences in the Akt and Erk signalling pathways in dominant compared to subordinate follicles. The aim of this study was to investigate the effects of inhibiting Akt and Erk phosphorylation on IGF- and gonadotropin- stimulated granulosa and theca cell function in vitro, and on follicle development in vivo.
Bovine granulosa and theca cells were cultured for six days and stimulated with FSH and/or IGF, or LH in combination with PD98059 (Erk inhibitor) and/or LY294002 (Akt inhibitor) and their effect on cell number and hormone secretion (estradiol, activin-A, inhibin-A, follistatin, progesterone and androstenedione) determined. In addition, ovarian follicles were treated in vivo with PD98059 and/or LY294002 in ewes on Day 3 of the cycle and follicles were recovered 48 hours later.
We have shown that gonadotropin- and IGF-stimulated hormone production by granulosa and theca cells is reduced by treatment with PD98059 and LY294002 in vitro. Furthermore, treatment with PD98059 and LY294002 reduced follicle growth and oestradiol production in vivo.
These results demonstrate an important functional role for the Akt and Erk signalling pathways in follicle function, growth and development.

Download full-text


Available from: Phil G Knight
  • Source
    • "This hormone has been shown to modulate phosphorylation of MAPK (ERK1/2, p38, and JNK; Di Simone et al. 2009, Chen et al. 2010), AKT (Palanivel et al. 2006), and AMPK (Satoh et al. 2004) in different cell types. These signaling pathways have been described to play a role in steroidogenesis and/or proliferation of GCs in response to various hormones such as FSH, IGF1, and insulin, as well as more recently to some adipokines including leptin and adiponectin (Moore et al. 2001, Kayampilly & Menon 2004, Tosca et al. 2005, Yu et al. 2005, Ryan et al. 2008, Kayampilly & Menon 2009). Since the majority of resistin effects on rat and bovine steroidogenesis and proliferation were observed from the physiological level (10 ng/ml) in our study, we then examined the effect of this dose on phosphorylation of AKT, ERK1/2, p38-MAPK, and AMPKa in bovine and rat GCs for 1–120 min. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Resistin, initially identified in adipose tissue and macrophages, was implicated in insulin resistance. Recently, its mRNA was found in hypothalamo-pituitary axis and rat testis, leading us to hypothesize that resistin may be expressed in ovary. In this study, we determined in rats and cows 1) the characterization of resistin in ovary by RT-PCR, immunoblotting, and immunohistochemistry and 2) the effects of recombinant resistin (10, 100, 333, and 667 ng/ml) ± IGF1 (76 ng/ml) on steroidogenesis, proliferation, and signaling pathways of granulosa cells (GC) measured by enzyme immunoassay, [(3)H]thymidine incorporation, and immunoblotting respectively. We observed that resistin mRNA and protein were present in several bovine and rat ovarian cells. Nevertheless, only bovine GC abundantly expressed resistin mRNA and protein. Resistin treatment decreased basal but not IGF1-induced progesterone (P<0.05; whatever the dose) and estradiol (P<0.005; for 10 and 333 ng/ml) production by bovine GC. In rats, resistin (10 ng/ml) increased basal and IGF1-induced progesterone secretion (P<0.0001), without effect on estradiol release. We found no effect of resistin on rat GC proliferation. Conversely, in cows, resistin increased basal proliferation (P<0.0001; for 100-667 ng/ml) and decreased IGF1-induced proliferation of GC (P<0.0001; for 10-333 ng/ml) associated with a decrease in cyclin D2 protein level (P<0.0001). Finally, resistin stimulated AKT and p38-MAPK phosphorylation in both species, ERK1/2-MAPK phosphorylation in rats and had the opposite effect on the AMPK pathway (P<0.05). In conclusion, our results show that resistin is expressed in rat and bovine ovaries. Furthermore, it can modulate GC functions in basal state or in response to IGF1 in vitro.
    Full-text · Article · Mar 2011 · Reproduction
  • Source
    • "In porcine endometrial cells, the LH hormone activates both cAMP/PKA and PLC/inositide tris-phosphate pathways [21]. Moreover, LH acting through the Akt and Erk pathways on theca cells plays a relevant function in vitro and follicle growth and development [22] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Endometrial cancer (EC) is a hormone-dependent cancer that currently represents the most frequent malignancy of the female reproductive tract. The involvement of steroid hormones in EC etiology and progression has been reported. More recently, gonadotropins, and, in particular LH/hCG, are emerging as novel regulators of tumor progression. In the present review, we discuss the role of the LH/hCG axis (i.e. LH/hCG and its receptors, LH/hCG-R) in both gonadal and nongonadal tissues, in physiological and neoplastic conditions. In cancer cells, LH/hCG mainly controls cell proliferation and apoptosis. In particular, in EC LH/hCG improves cell invasiveness, through a mechanism which involves the LH/hCG-R, which in turn activate protein kinase A and modulate integrin adhesion receptors. Indeed, the LH/hCG-R mRNA is expressed in primary ECs and this expression correlates with LH/hCG-induced cell invasiveness in vitro. These results lead to hypothesize that recurrent and metastatic ECs, which express LH/hCG-R, could benefit from therapies aimed at decreasing LH levels, through Gn-RH analogues. Hence, the LH/hCG axis could represent a prognostic factor and a new therapeutic target in EC.
    Full-text · Article · Jul 2010 · Obstetrics and Gynecology International
  • Source
    • "Adiponectin rapidly and transiently activated ERK1/2 MAPK in bovine granulosa cells, as previously described in porcine, rat, chicken and human granulosa cells [2,15,16,40]. The ERK1/2 MAPK and/or Akt signaling pathways have been potentially involved in the steroid production in rat [50,51] and bovine [52,53] granulosa cells. To understand through which pathway adiponectin decreased insulin-induced steroidogenesis in bovine granulosa cells, we analyzed the pattern of ERK1/2 MAPK and Akt phosphorylation in bovine granulosa cells cultured with rh adiponectin (10 μg/mL) for 24 h and then with insulin (10-8 M) for 5 min. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Adiponectin is an adipokine, mainly produced by adipose tissue. It regulates several reproductive processes. The protein expression of the adiponectin system (adiponectin, its receptors, AdipoR1 and AdipoR2 and the APPL1 adaptor) in bovine ovary and its role on ovarian cells and embryo, remain however to be determined. Here, we identified the adiponectin system in bovine ovarian cells and embryo using RT-PCR, immunoblotting and immunohistochemistry. Furthermore, we investigated in vitro the effects of recombinant human adiponectin (10 micro g/mL) on proliferation of granulosa cells (GC) measured by [3H] thymidine incorporation, progesterone and estradiol secretions measured by radioimmunoassay in the culture medium of GC, nuclear oocyte maturation and early embryo development. We show that the mRNAs and proteins for the adiponectin system are present in bovine ovary (small and large follicles and corpus luteum) and embryo. Adiponectin, AdipoR1 and AdipoR2 were more precisely localized in oocyte, GC and theca cells. Adiponectin increased IGF-1 10(-8) M-induced GC proliferation (P < 0.01) but not basal or insulin 10(-8) M-induced proliferation. Additionally, adiponectin decreased insulin 10(-8) M-induced, but not basal or IGF-1 10(-8) M-induced secretions of progesterone (P < 0.01) and estradiol (P < 0.05) by GC. This decrease in insulin-induced steroidogenesis was associated with a decrease in ERK1/2 MAPK phosphorylation in GC pre-treated with adiponectin. Finally, addition of adiponectin during in vitro maturation affected neither the percentage of oocyte in metaphase-II nor 48-h cleavage and blastocyst day 8 rates. In bovine species, adiponectin decreased insulin-induced steroidogenesis and increased IGF-1-induced proliferation of cultured GC through a potential involvement of ERK1/2 MAPK pathway, whereas it did not modify oocyte maturation and embryo development in vitro.
    Full-text · Article · Mar 2010 · Reproductive Biology and Endocrinology
Show more